Goserelin acetate
USP/1297205 - United States Pharmacopeia (USP) Reference Standard
Synonym: [D-Ser(tBu)6,Azagly10]-LHRH acetate salt
CAS Number: 145781-92-6
Empirical Formula (Hill Notation): C59H84N18O14
Molecular Weight: 1269.41
MDL Number: MFCD01747329
Linear Formula: C59H84N18O14
Product Type: Chemical
| API family | goserelin |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | powder |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C59H84N18O14.C2H4O2/c1 |
| InChI key | IKDXDQDKCZPQSZ-JHYYTBFNSA |
| manufacturer/tradename | USP |
| SMILES string | CC(O)=O.CC(C)C[C@H](NC(=O |
| storage temp. | −20°C |
| Amino Acid Sequence: | Glp-His-Trp-Ser-Tyr-Ser(t |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Goserelin acetate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Goserelin Implants |
| Biochem/physiol Actions: | Goserelin is a synthetic analog of LHRH (leutinizing hormone releasing hormone). Goserelin is a LHRH agonist It is used in prostate cancer and breast cancer therapies and also in the treatment of endometriosis. |
| General description: | A GnRH analog utilized in hormone-sensitive cancers. Peptide family: Goserelin The USP biologics peptides category encompasses a diverse range of therapeutic peptides that are essential in managing various medical conditions. These peptides, typically consisting of amino acid sequences of 40 residues or less, are critical for the development of high-quality medicines. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of peptide therapeutics throughout their lifecycle. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360 |
| Precautionary statements | P201 - P280 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 41116107 |


